Related Experiment Video
Updated: Jul 10, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
Mixed meal simulation model of glucose-insulin system
Chiara Dalla Man1, Robert A Rizza, Claudio Cobelli
1Dept. of Information Engineering, University of Padova, Italy. chiara.dallaman@dei.unipd.it
Summary
This study introduces a new glucose-insulin system simulation model for postprandial states. It accurately simulates glucose and insulin dynamics in normal and diabetic conditions, aiding diabetes research.
Area of Science:
- Physiology
- Biomedical Engineering
- Computational Biology
Background:
- Understanding the glucose-insulin system post-meal is crucial for diabetes pathophysiology research.
- Recent advancements provide quantitative data for improved physiological modeling.
Purpose of the Study:
- To develop a novel simulation model of the glucose-insulin system in the postprandial state.
- To utilize recent quantitative knowledge for enhanced physiological event description after meals.
Main Methods:
- Developed a new simulation model incorporating recent quantitative physiological data.
- Calibrated model parameters using data from 204 normal subjects undergoing a triple tracer meal protocol.
- Estimated major glucose and insulin fluxes with quasi model-independent accuracy.
Main Results:
- The model successfully describes glucose-insulin dynamics during daily meals (breakfast, lunch, dinner) in normal subjects.
- The model simulates both normal physiological and pathophysiological conditions relevant to diabetes.
- Simulations demonstrate the model's utility in exploring type 1 diabetes management strategies.
Conclusions:
- The developed simulation model provides a valuable tool for studying diabetes pathophysiology.
- The model accurately represents postprandial glucose-insulin dynamics and can be applied to various conditions.
- It shows potential for simulating insulin infusion strategies in type 1 diabetes research.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:02Glucose Homeostasis: Regulation of Blood Glucose
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:01Feedback Loops
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...